statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	270
IT - Italia	118
SG - Singapore	114
CN - Cina	63
HK - Hong Kong	55
KR - Corea	54
IN - India	47
NZ - Nuova Zelanda	39
BR - Brasile	36
DE - Germania	33
GB - Regno Unito	32
IE - Irlanda	20
JP - Giappone	16
FI - Finlandia	14
CL - Cile	13
RU - Federazione Russa	11
BE - Belgio	10
FR - Francia	10
TR - Turchia	10
SE - Svezia	9
CA - Canada	8
ES - Italia	8
NL - Olanda	8
VN - Vietnam	6
ID - Indonesia	5
MX - Messico	5
PL - Polonia	5
UA - Ucraina	5
AU - Australia	4
CO - Colombia	4
LU - Lussemburgo	4
PK - Pakistan	4
BD - Bangladesh	3
IL - Israele	3
IR - Iran	3
PT - Portogallo	3
UZ - Uzbekistan	3
ZA - Sudafrica	3
AE - Emirati Arabi Uniti	2
AR - Argentina	2
CZ - Repubblica Ceca	2
LT - Lituania	2
RO - Romania	2
TW - Taiwan	2
AM - Armenia	1
AO - Angola	1
AT - Austria	1
BG - Bulgaria	1
EG - Egitto	1
GH - Ghana	1
IQ - Iraq	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LV - Lettonia	1
NP - Nepal	1
PH - Filippine	1
PS - Palestinian Territory	1
PY - Paraguay	1
SA - Arabia Saudita	1
SC - Seychelles	1
SK - Slovacchia (Repubblica Slovacca)	1
VE - Venezuela	1
Totale	1.089

Nome	#
Dissecting the pathophysiology of alpha-synuclein and synapsin III interaction in conventional and patient-derived models of Parkinson’s disease	543
The good and bad of therapeutic strategies that directly target α-synuclein	102
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders	96
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?	73
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice	70
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype	64
Nanorod-associated plasmonic circular dichroism monitors the handedness and composition of α-synuclein fibrils from Parkinson's disease models and post-mortem brain	54
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease	49
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease	49
Totale	1.100

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	12	0	0	0	0	0	1	0	3	1	3	1	3
2021/2022	40	0	0	6	1	0	9	0	6	3	3	6	6
2022/2023	77	3	0	0	1	0	6	1	11	17	14	15	9
2023/2024	265	26	26	16	18	8	34	30	13	29	17	30	18
2024/2025	389	22	15	22	32	33	30	61	30	30	40	47	27
2025/2026	286	50	45	31	77	78	5	0	0	0	0	0	0
Totale													1.100